Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Cervical Cancer

  Free Subscription


1 Acta Cytol
1 Acta Oncol
2 Am J Cancer Res
1 Asian J Surg
1 Best Pract Res Clin Obstet Gynaecol
3 Biosci Rep
4 BMC Cancer
1 BMC Infect Dis
1 BMC Public Health
8 BMC Womens Health
1 BMJ Open
1 Br J Radiol
1 Can Bull Med Hist
1 Cancer Causes Control
1 Cancer Control
1 Cancer Invest
1 Cancer Med
1 Cancer Sci
1 Cancer Treat Rev
2 Cancers (Basel)
1 Clin Immunol
1 Clin Oncol (R Coll Radiol)
1 Contrast Media Mol Imaging
1 Cytokine
1 Diagnostics (Basel)
1 Environ Health Prev Med
2 Environ Toxicol
1 Eur J Obstet Gynecol Reprod Biol
1 Eur J Radiol
2 Exp Ther Med
2 FEBS Open Bio
1 Front Cell Dev Biol
1 Front Genet
3 Front Oncol
4 Gynecol Oncol
1 Gynecol Oncol Rep
1 Health Equity
1 Indian J Cancer
1 Indian J Gynecol Oncol
1 Infez Med
3 Int J Cancer
3 Int J Clin Oncol
1 Int J Gynaecol Obstet
1 Int J Gynecol Cancer
1 Int J Infect Dis
1 Int J Med Sci
1 Int J Mol Med
1 Int J Mol Sci
1 J Cancer
2 J Clin Med
1 J Gynecol Oncol
1 J Low Genit Tract Dis
1 J Med Case Rep
3 J Minim Invasive Gynecol
1 J Obstet Gynaecol
1 J Obstet Gynaecol Res
1 J Pediatr Adolesc Gynecol
2 J Pers Med
1 J Radiat Res
1 J Transl Med
1 JBI Evid Synth
1 JCI Insight
4 JCO Glob Oncol
1 Lancet Infect Dis
1 Mar Drugs
1 Med Clin (Barc)
1 Med J Malaysia
1 Medicina (Kaunas)
1 Medicine (Baltimore)
1 Microrna
1 MMW Fortschr Med
1 Mol Cell Biochem
1 Mol Clin Oncol
1 Mol Med Rep
2 Molecules
1 Nat Methods
1 Oncol Lett
2 Oncol Rep
1 PLoS One
1 Pol J Pathol
1 Psychooncology
1 Public Health
1 Radiol Med
1 Radiol Phys Technol
1 Reprod Sci
1 Rev Med Liege
1 Sci Rep
1 Strahlenther Onkol
2 Womens Health (Lond)
1 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Cytol

  1. EDVARDSSON H, Wang J, Andrae B, Sparen P, et al
    Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
    Acta Cytol. 2021 Jun 2:1-8. doi: 10.1159/000515912.
    PubMed         Abstract available

    Acta Oncol

  2. AHANGARI S, Hansen NL, Olin AB, Nottrup TJ, et al
    Toward PET/MRI as one-stop shop for radiotherapy planning in cervical cancer patients.
    Acta Oncol. 2021 Jun 9:1-9. doi: 10.1080/0284186X.2021.1936164.
    PubMed         Abstract available

    Am J Cancer Res

  3. RAMAKRISHNAN V, de Haydu C, Wilkinson P, Hooda U, et al
    Minnelide, a prodrug, inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb.
    Am J Cancer Res. 2021;11:2202-2214.
    PubMed         Abstract available

  4. GOU Y, Li F, Huo X, Hao C, et al
    ENO1 monoclonal antibody inhibits invasion, proliferation and clone formation of cervical cancer cells.
    Am J Cancer Res. 2021;11:1946-1961.
    PubMed         Abstract available

    Asian J Surg

  5. JING H, Ran X, Li Z
    Application of novel tumor-free techniques in laparoscopic radical hysterectomy for early cervical cancer.
    Asian J Surg. 2021 May 30. pii: S1015-9584(21)00258.

    Best Pract Res Clin Obstet Gynaecol

  6. IND T
    Overview of fertility sparing treatments for cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2021 May 6. pii: S1521-6934(21)00066.
    PubMed         Abstract available

    Biosci Rep

  7. Retraction: Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p.
    Biosci Rep. 2021;41.

  8. Retraction: HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targeting miR-23b/MAPK1 axis.
    Biosci Rep. 2021;41.

  9. PANDEY P, Khan F, Farhan M, Jafri A, et al
    Elucidation of Rutin role in inducing caspase dependent apoptosis via HPV-E6 and E7 downregulation in cervical cancer HeLa cells.
    Biosci Rep. 2021 Jun 10. pii: 228976. doi: 10.1042/BSR20210670.
    PubMed         Abstract available

    BMC Cancer

  10. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:682.
    PubMed         Abstract available

  11. ZOU D, Guo M, Zhou Q
    A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
    BMC Cancer. 2021;21:661.
    PubMed         Abstract available

  12. RAKHSHANDA S, Dalal K, Chowdhury HA, Mayaboti CA, et al
    Assessing service availability and readiness to manage cervical cancer in Bangladesh.
    BMC Cancer. 2021;21:670.
    PubMed         Abstract available

  13. ZHAO J, Cao H, Zhang W, Fan Y, et al
    SOX14 hypermethylation as a tumour biomarker in cervical cancer.
    BMC Cancer. 2021;21:675.
    PubMed         Abstract available

    BMC Infect Dis

  14. ARANDA FLORES CE, Gomez Gutierrez G, Ortiz Leon JM, Cruz Rodriguez D, et al
    Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
    BMC Infect Dis. 2021;21:504.
    PubMed         Abstract available

    BMC Public Health

  15. OKYERE J, Duodu PA, Aduse-Poku L, Agbadi P, et al
    Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys.
    BMC Public Health. 2021;21:1071.
    PubMed         Abstract available

    BMC Womens Health

  16. HE R, Zhu B, Liu J, Zhang N, et al
    Women's cancers in China: a spatio-temporal epidemiology analysis.
    BMC Womens Health. 2021;21:116.
    PubMed         Abstract available

  17. KAMATH MULKI A, Withers M
    Human Papilloma Virus self-sampling performance in low- and middle-income countries.
    BMC Womens Health. 2021;21:12.
    PubMed         Abstract available

  18. BOOTH BB, Petersen LK, Blaakaer J, Johansen T, et al
    Can the dynamic spectral imaging (DSI) color map improve colposcopy examination for precancerous cervical lesions? A prospective evaluation of the DSI color map in a multi-biopsy clinical setting.
    BMC Womens Health. 2021;21:21.
    PubMed         Abstract available

  19. CARRILLO T, Montealegre JR, Bracamontes CG, Scheurer ME, et al
    Predictors of timely diagnostic follow-up after an abnormal Pap test among Hispanic women seeking care in El Paso, Texas.
    BMC Womens Health. 2021;21:11.
    PubMed         Abstract available

  20. WANG X, Xu J, Gao Y, Qu P, et al
    Necessity for subsequent surgery in women of child-bearing age with positive margins after conization.
    BMC Womens Health. 2021;21:191.
    PubMed         Abstract available

  21. BUICK C, Murphy KJ, Howell D, Metcalfe K, et al
    Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology.
    BMC Womens Health. 2021;21:29.
    PubMed         Abstract available

  22. SHEN Y, Xia J, Li H, Xu Y, et al
    Human papillomavirus infection rate, distribution characteristics, and risk of age in pre- and postmenopausal women.
    BMC Womens Health. 2021;21:80.
    PubMed         Abstract available

  23. QADERI K, Mirmolaei ST, Geranmayeh M, Sheikh Hasani S, et al
    Iranian women's psychological responses to positive HPV test result: a qualitative study.
    BMC Womens Health. 2021;21:128.
    PubMed         Abstract available

    BMJ Open

  24. NNAJI CA, Kuodi P, Walter FM, Moodley J, et al
    Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review protocol.
    BMJ Open. 2021;11:e044093.
    PubMed         Abstract available

    Br J Radiol

  25. WANG H, Wang R, Liu J, Zhang J, et al
    Tree-based exploration of the optimization objectives for automatic cervical cancer IMRT treatment planning.
    Br J Radiol. 2021 Jun 11:20210214. doi: 10.1259/bjr.20210214.
    PubMed         Abstract available

    Can Bull Med Hist

  26. FRASER J
    Seizing the Means of Reproduction? Canada, Cancer Screening, and the Colonial History of the Cytopipette.
    Can Bull Med Hist. 2021;38:128-176.
    PubMed         Abstract available

    Cancer Causes Control

  27. JULIAN MCFARLANE S, Morgan SE, Schlumbrecht M
    Acceptability of a multicomponent, community-based, HPV self-test intervention among Jamaican women.
    Cancer Causes Control. 2021;32:547-554.
    PubMed         Abstract available

    Cancer Control

  28. JIN F, Liu Q, Luo H, Zhu R, et al
    Dynamic Changes in Bladder Morphology Over Time in Cervical Cancer Patients.
    Cancer Control. 2021;28:10732748211021082.
    PubMed         Abstract available

    Cancer Invest

  29. ABDEL-HAMID NM, Fathy M, Koike C, Yoshida T, et al
    Identification of Chemo and Radio-resistant Sub-population of Stem Cells in Human Cervical Cancer HeLa Cells.
    Cancer Invest. 2021 Jun 2:1-27. doi: 10.1080/07357907.2021.1931875.
    PubMed         Abstract available

    Cancer Med

  30. JI X, Sui L, Song K, Lv T, et al
    PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer.
    Cancer Med. 2021 Jun 2. doi: 10.1002/cam4.4034.
    PubMed         Abstract available

    Cancer Sci

  31. YAMAGUCHI K, Matsumoto Y, Suzuki R, Nishida H, et al
    Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers.
    Cancer Sci. 2021;112:2493-2503.
    PubMed         Abstract available

    Cancer Treat Rev

  32. CROWLEY FJ, O'Cearbhaill RE, Collins DC
    Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.
    Cancer Treat Rev. 2021;98:102225.
    PubMed         Abstract available

    Cancers (Basel)

  33. CHEN YH, Wang PH, Chen PN, Yang SF, et al
    Molecular and Cellular Mechanisms of Metformin in Cervical Cancer.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available

  34. CIBULA D, Borcinova M, Marnitz S, Jarkovsky J, et al
    Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available

    Clin Immunol

  35. ZHANG W, Shan H, Jiang K, Huang W, et al
    A novel intracellular nanobody against HPV16 E6 oncoprotein.
    Clin Immunol. 2021;225:108684.
    PubMed         Abstract available

    Clin Oncol (R Coll Radiol)

  36. UWINS C, Patel H, Prakash Bhandoria G, Butler-Manuel S, et al
    Laparoscopic and Robotic Surgery for Endometrial and Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2021 May 27. pii: S0936-6555(21)00178.
    PubMed         Abstract available

    Contrast Media Mol Imaging

  37. LIN TT, Li XX, Lv WF, Dong JN, et al
    Diagnostic Value of Combined Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Diffusion Tensor Imaging in Predicting Parametrial Infiltration in Cervical Cancer.
    Contrast Media Mol Imaging. 2021;2021:6651070.
    PubMed         Abstract available


  38. TRUJILLO-CIRILO L, Torres-Corioriles EI, Rangel-Corona R, Corona-Ortega MT, et al
    Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells.
    Cytokine. 2021 Jun 4:155592. doi: 10.1016/j.cyto.2021.155592.
    PubMed         Abstract available

    Diagnostics (Basel)

  39. AREZZO F, Cormio G, Loizzi V, Cazzato G, et al
    HPV-Negative Cervical Cancer: A Narrative Review.
    Diagnostics (Basel). 2021;11.
    PubMed         Abstract available

    Environ Health Prev Med

    A cross-sectional study to assess knowledge of women about cervical cancer: an urban and rural comparison.
    Environ Health Prev Med. 2021;26:64.
    PubMed         Abstract available

    Environ Toxicol

  41. LIU X, Shen X, Zhang J
    TRIP13 exerts a cancer-promoting role in cervical cancer by enhancing Wnt/beta-catenin signaling via ACTN4.
    Environ Toxicol. 2021 Jun 1. doi: 10.1002/tox.23303.
    PubMed         Abstract available

    Brucine promotes apoptosis in cervical cancer cells (ME-180) via suppression of inflammation and cell proliferation by regulating PI3K/AKT/mTOR signaling pathway.
    Environ Toxicol. 2021 Jun 2. doi: 10.1002/tox.23304.
    PubMed         Abstract available

    Eur J Obstet Gynecol Reprod Biol

  43. REICH O, Pickel H
    100 years of iodine testing of the cervix: A critical review and implications for the future.
    Eur J Obstet Gynecol Reprod Biol. 2021;261:34-40.
    PubMed         Abstract available

    Eur J Radiol

  44. QIN F, Pang H, Ma J, Zhao M, et al
    Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Eur J Radiol. 2021;141:109787.
    PubMed         Abstract available

    Exp Ther Med

  45. ZHANG P, Lin Y, Liu Y
    CLCA2 suppresses the proliferation, migration and invasion of cervical cancer.
    Exp Ther Med. 2021;22:776.
    PubMed         Abstract available

  46. GUO R, Liu G, Li C, Liu X, et al
    B7 homolog 6 promotes the progression of cervical cancer.
    Exp Ther Med. 2021;22:774.
    PubMed         Abstract available

    FEBS Open Bio

  47. SHI Z, Wu D, Xu H, Yang J, et al
    CSNK2A1-mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer.
    FEBS Open Bio. 2021 Jun 11. doi: 10.1002/2211-5463.13228.
    PubMed         Abstract available

  48. ZHU K, Bai H, Mu M, Xue Y, et al
    Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signalling.
    FEBS Open Bio. 2021 Jun 3. doi: 10.1002/2211-5463.13216.
    PubMed         Abstract available

    Front Cell Dev Biol

  49. ZHU J, Kamara S, Wang Q, Guo Y, et al
    Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells.
    Front Cell Dev Biol. 2021;9:677867.
    PubMed         Abstract available

    Front Genet

  50. XU F, Shen J, Xu S
    Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment.
    Front Genet. 2021;12:663617.
    PubMed         Abstract available

    Front Oncol

  51. JAYAMOHAN S, Kannan M, Moorthy RK, Rajasekaran N, et al
    Corrigendum: Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.
    Front Oncol. 2021;11:694442.
    PubMed         Abstract available

  52. PARK SJ, Mun J, Lee S, Luo Y, et al
    Laterally Extended Endopelvic Resection Versus Chemo or Targeted Therapy Alone for Pelvic Sidewall Recurrence of Cervical Cancer.
    Front Oncol. 2021;11:683441.
    PubMed         Abstract available

  53. HUANG SK, Ni RX, Wang WJ, Wang D, et al
    Overexpression of LINC00673 Promotes the Proliferation of Cervical Cancer Cells.
    Front Oncol. 2021;11:669739.
    PubMed         Abstract available

    Gynecol Oncol

  54. MILLS JM, Morgan JR, Dhaliwal A, Perkins RB, et al
    Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.
    Gynecol Oncol. 2021 Jun 3. pii: S0090-8258(21)00441.
    PubMed         Abstract available

  55. SERT BM, Kristensen GB, Kleppe A, Dorum A, et al
    Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
    Gynecol Oncol. 2021 May 31. pii: S0090-8258(21)00434.
    PubMed         Abstract available

  56. BRODEUR MN, Dejean R, Beauchemin MC, Samouelian V, et al
    Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00429.
    PubMed         Abstract available

  57. SONG F, Belinson JL, Yan P, Huang X, et al
    Evaluation of p16(INK4a) immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
    Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00410.
    PubMed         Abstract available

    Gynecol Oncol Rep

  58. MUMBA JM, Kasonka L, Owiti OB, Andrew J, et al
    Cervical cancer diagnosis and treatment delays in the developing world: Evidence from a hospital-based study in Zambia.
    Gynecol Oncol Rep. 2021;37:100784.
    PubMed         Abstract available

    Health Equity

  59. GHEBRENDRIAS S, Pfeil S, Crouthamel B, Chalmiers M, et al
    An Examination of Misconceptions and Their Impact on Cervical Cancer Prevention Practices among Sub-Saharan African and Middle Eastern Refugees.
    Health Equity. 2021;5:382-389.
    PubMed         Abstract available


  60. YANG J, Liu W, Yan Z, Li C, et al
    Polymorphisms in transporter associated with antigen presenting are associated with cervical intraepithelial neoplasia and cervical cancer in a Chinese Han population.
    HLA. 2021 May 29. doi: 10.1111/tan.14333.
    PubMed         Abstract available

    Indian J Cancer

  61. SHYLASREE TS, Ranade R, Kattepur AK, Kaur S, et al
    Quality of life in long term survivors of cervical cancer: A cross sectional study.
    Indian J Cancer. 2021;58:171-178.
    PubMed         Abstract available

    Indian J Gynecol Oncol

  62. BHATLA N, Meena J, Kumari S, Banerjee D, et al
    Cervical Cancer Prevention Efforts in India.
    Indian J Gynecol Oncol. 2021;19:41.
    PubMed         Abstract available

    Infez Med

  63. MAVROMMATIS E, Lytsikas-Sarlis P, Troupis T
    Historical pearls of HPV research: from condyloma to cervical cancer.
    Infez Med. 2021;29:278-283.
    PubMed         Abstract available

    Int J Cancer

  64. INTURRISI F, Lissenberg-Witte BI, Veldhuijzen NJ, Bogaards JA, et al
    Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer.
    Int J Cancer. 2021;148:320-328.
    PubMed         Abstract available

  65. EL-ZEIN M, Gotlieb W, Gilbert L, Hemmings R, et al
    Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    Int J Cancer. 2021;148:492-501.
    PubMed         Abstract available

  66. BONDE J, Floore A, Ejegod D, Vink FJ, et al
    Methylation markers FAM19A4 and miR124-2 as triage strategy for primary HPV screen positive women; A large European multi-center study.
    Int J Cancer. 2020 Sep 30. doi: 10.1002/ijc.33320.
    PubMed         Abstract available

    Int J Clin Oncol

  67. CHOI HG, Lee JW, Min CY, Yoo DM, et al
    Analyses of the association between cervical cancer and osteoporosis/osteoporotic fracture: a cross-sectional study using KoGES HEXA data.
    Int J Clin Oncol. 2021 Jun 6. pii: 10.1007/s10147-021-01951.
    PubMed         Abstract available

  68. NARA K, Taguchi A, Tojima Y, Miyamoto Y, et al
    History of whole pelvis plus para-aortic radiation is a risk factor associated with febrile neutropenia during chemotherapy for recurrent cervical cancer.
    Int J Clin Oncol. 2021 Jun 4. pii: 10.1007/s10147-021-01950.
    PubMed         Abstract available

  69. TSUJI K, Shimada M, Takahashi F, Tokunaga H, et al
    Clinico-pathological characteristics of patients with stage IB1-IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan.
    Int J Clin Oncol. 2021 Jun 9. pii: 10.1007/s10147-021-01938.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  70. TIMOTEO-LIAINA I, Khozaim K, Chen YA, Buenconsejo-Lum L, et al
    The rising relative and absolute incidence of uterine cancer in specific populations.
    Int J Gynaecol Obstet. 2020 Feb 29. doi: 10.1002/ijgo.13130.
    PubMed         Abstract available

    Int J Gynecol Cancer

  71. CHILINDA G, Massamba L, Meja S, Ngo C, et al
    Implementing a comprehensive cervical cancer program in Southern Malawi: a 'Medecins Sans Frontieres', Ministry of Health, and College of Medicine of Blantyre Collaborative Project.
    Int J Gynecol Cancer. 2021 Jun 2. pii: ijgc-2021-002743.

    Int J Infect Dis

  72. TOUNKARA FK, Teguete I, Guedou FA, Talbot D, et al
    Type-specific incidence, persistence and factors associated with human papillomavirus infection among female sex workers in Benin and Mali, West Africa.
    Int J Infect Dis. 2021;106:348-357.
    PubMed         Abstract available

    Int J Med Sci

  73. PAEK J, Lim PC
    The early surgical period in robotic radical hysterectomy is related to the recurrence after surgery in stage IB cervical cancer.
    Int J Med Sci. 2021;18:2697-2704.
    PubMed         Abstract available

    Int J Mol Med

  74. ZHONG J, Yuan H, Xu X, Kong S, et al
    [Retracted] MicroRNA195 inhibits cell proliferation, migration and invasion by targeting defective in cullin neddylation 1 domain containing 1 in cervical cancer.
    Int J Mol Med. 2021;48.
    PubMed         Abstract available

    Int J Mol Sci

  75. GRANADOS-LOPEZ AJ, Manzanares-Acuna E, Lopez-Hernandez Y, Castaneda-Delgado JE, et al
    UVB Inhibits Proliferation, Cell Cycle and Induces Apoptosis via p53, E2F1 and Microtubules System in Cervical Cancer Cell Lines.
    Int J Mol Sci. 2021;22.
    PubMed         Abstract available

    J BUON

  76. WU J, Wang N, Jin G, Xue L, et al
    Tormentic acid induces anticancer effects in cisplatin-resistant human cervical cancer cells mediated via cell cycle arrest, ROS production, and targeting mTOR/PI3K/AKT signalling pathway.
    J BUON. 2021;26:643.
    PubMed         Abstract available

  77. YU L, Sun Y, Su J, Li X, et al
    Bismahanine exerts anticancer effects on human cervical cancer cells by inhibition of growth, migration and invasion via suppression of NF-kB signalling pathway.
    J BUON. 2021;26:644.
    PubMed         Abstract available

    J Cancer

  78. HUANG X, Neckenig M, Sun J, Jia D, et al
    Vitamin E succinate exerts anti-tumour effects on human cervical cancer cells via the CD47-SIRPa pathway both in vivo and in vitro.
    J Cancer. 2021;12:3877-3886.
    PubMed         Abstract available

    J Clin Med

  79. CHO O, Kim DW, Cheong JY
    Plasma Exosomal miRNA Levels after Radiotherapy Are Associated with Early Progression and Metastasis of Cervical Cancer: A Pilot Study.
    J Clin Med. 2021;10.
    PubMed         Abstract available

  80. LEE JW, Seol KH
    Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer.
    J Clin Med. 2021;10.
    PubMed         Abstract available

    J Gynecol Oncol

    Towards the elimination of cervical cancer in Japan.
    J Gynecol Oncol. 2021;32:e76.

    J Low Genit Tract Dis

  82. CANTWELL CJ, Moroney MR, Sheeder J, Guntupalli SR, et al
    Assessing Inequities in Cervical Cancer Quality of Care and Survival Related to Ethnicity and Socioeconomic Factors.
    J Low Genit Tract Dis. 2021 May 28. pii: 00128360-900000000-99342.
    PubMed         Abstract available

    J Med Case Rep

  83. ESMAT E, Malakzai HA, Haidari M, Haidary AM, et al
    Giant hamartomatous polyp of the uterine cervix with heterologous mesenchymal tissue in a child: a case report.
    J Med Case Rep. 2021;15:279.
    PubMed         Abstract available

    J Minim Invasive Gynecol

    The Modified Schauta-Stoeckel Procedure.
    J Minim Invasive Gynecol. 2021;28:391.
    PubMed         Abstract available

  85. ROSSI EC, Tanner E
    Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies.
    J Minim Invasive Gynecol. 2021;28:409-417.
    PubMed         Abstract available

  86. KOHN JR, Katebi Kashi P, Acosta-Torres S, Beavis AL, et al
    Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers.
    J Minim Invasive Gynecol. 2021;28:392-402.
    PubMed         Abstract available

    J Obstet Gynaecol

  87. CHEN H, Li H, Wang L, Li Y, et al
    A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer.
    J Obstet Gynaecol. 2021 Jun 4:1-6. doi: 10.1080/01443615.2021.1907563.
    PubMed         Abstract available

    J Obstet Gynaecol Res

  88. YAMAZAKI H, Mitamura T, Ihira K, Endo D, et al
    The difficulty to diagnose cervical cancer developing in the perinatal period with the first-trimester cytology: A retrospective study.
    J Obstet Gynaecol Res. 2021 Jun 9. doi: 10.1111/jog.14882.
    PubMed         Abstract available

    J Pediatr Adolesc Gynecol

  89. EVANS M, Lawson A, Jarin JD, Wilson EE, et al
    Squamous Carcinoma of the Cervix in a 15-Year-Old with Congenital HIV: A Case Report.
    J Pediatr Adolesc Gynecol. 2021;34:234-237.
    PubMed         Abstract available

    J Pers Med

  90. MKRTCHIAN L, Zamulaeva I, Krikunova L, Kiseleva V, et al
    HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer.
    J Pers Med. 2021;11.
    PubMed         Abstract available

  91. LUCIA F, Bourbonne V, Visvikis D, Miranda O, et al
    Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer.
    J Pers Med. 2021;11.
    PubMed         Abstract available

    J Radiat Res

  92. TSUJII K, Ueda Y, Isono M, Miyazaki M, et al
    Dosimetric impact of rotational setup errors in volumetric modulated arc therapy for postoperative cervical cancer.
    J Radiat Res. 2021 May 29. pii: 6288073. doi: 10.1093.
    PubMed         Abstract available

    J Transl Med

  93. GAO Z, Wang Q, Ji M, Guo X, et al
    Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis.
    J Transl Med. 2021;19:229.
    PubMed         Abstract available

    JBI Evid Synth

  94. STIRLING CAMERON E, Almukhaini S, Dol J, Aston M, et al
    Access and use of sexual and reproductive health services among resettled refugee and refugee-claimant women in high-income countries: a scoping review protocol.
    JBI Evid Synth. 2021;19:604-613.
    PubMed         Abstract available

    JCI Insight

  95. BALANCA CC, Salvioni A, Scarlata CM, Michelas M, et al
    PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
    JCI Insight. 2021;6.
    PubMed         Abstract available

    JCO Glob Oncol

  96. KRAKAUER EL, Kane K, Kwete X, Afshan G, et al
    Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population.
    JCO Glob Oncol. 2021;7:873-885.
    PubMed         Abstract available

  97. MOHANTY S, Gurram L, Chopra S, Mahantshetty U, et al
    Cervical Cancer Treatment in HIV-Positive Patients: A Survey of Treatment Practices in India.
    JCO Glob Oncol. 2021;7:843-848.
    PubMed         Abstract available

  98. KRAKAUER EL, Kwete X, Kane K, Afshan G, et al
    Cervical Cancer-Associated Suffering: Estimating the Palliative Care Needs of a Highly Vulnerable Population.
    JCO Glob Oncol. 2021;7:862-872.
    PubMed         Abstract available

  99. KRAKAUER EL, Kane K, Kwete X, Afshan G, et al
    Augmented Package of Palliative Care for Women With Cervical Cancer: Responding to Refractory Suffering.
    JCO Glob Oncol. 2021;7:886-895.
    PubMed         Abstract available


  100. LIMBACHIYA D, Kumari R
    Vaginal Closure Before Colpotomy with an Endo-Stapler to Prevent Tumor Spillage in Laparoscopic Surgery for Gynecological Malignancy.
    JSLS. 2021;25.
    PubMed         Abstract available

    Lancet Infect Dis

  101. HARPER DM, Jimbo M
    Elimination of cervical cancer depends on HPV vaccination and primary HPV screening.
    Lancet Infect Dis. 2021 May 28. pii: S1473-3099(20)30992.

    Mar Drugs

  102. YOUSSEF DTA, Asfour HZ, Genta-Jouve G, Shaala LA, et al
    Magnificines A and B, Antimicrobial Marine Alkaloids Featuring a Tetrahydrooxazolo[3,2-a]azepine-2,5(3H,6H)-dione Backbone from the Red Sea Sponge Negombata magnifica.
    Mar Drugs. 2021;19.
    PubMed         Abstract available

    Med Clin (Barc)

  103. PONS L, Carballas E, Tapia G
    Primary diffuse large B cell lymphoma of the cervix.
    Med Clin (Barc). 2021;156:530-531.

    Med J Malaysia

  104. TAN CS, Hamzah ND, Ismail ZHF, Jerip AR, et al
    Self-sampling in Human Papillomavirus screening during and post-COVID-19 pandemic.
    Med J Malaysia. 2021;76:298-303.
    PubMed         Abstract available

    Medicina (Kaunas)

  105. KAGABU M, Nagasawa T, Tatsuki S, Fukagawa Y, et al
    Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.
    Medicina (Kaunas). 2021;57.
    PubMed         Abstract available

    Medicine (Baltimore)

  106. ABDULAZIZ AMA, You X, Liu L, Sun Y, et al
    Management of high-grade squamous intraepithelial lesion patients with positive margin after LEEP conization: A retrospective study.
    Medicine (Baltimore). 2021;100:e26030.
    PubMed         Abstract available


  107. HOELZLE CR, Arnoult S, Borem CRM, Ottone M, et al
    microRNA Levels in Cervical Cancer Samples and Relationship with Lesion Grade and HPV Infection.
    Microrna. 2021 Jun 4. pii: MIRNA-EPUB-115982.
    PubMed         Abstract available

    MMW Fortschr Med

    [Cervical cancer is preventable today].
    MMW Fortschr Med. 2021;163:51-53.

    Mol Cell Biochem

  109. ROY R, Mandal S, Chakrabarti J, Saha P, et al
    Downregulation of Hyaluronic acid-CD44 signaling pathway in cervical cancer cell by natural polyphenols Plumbagin, Pongapin and Karanjin.
    Mol Cell Biochem. 2021 Jun 3. pii: 10.1007/s11010-021-04195.
    PubMed         Abstract available

    Mol Clin Oncol

  110. HU R, Saito AI, Mitsuhashi T, Inoue T, et al
    Radiosensitization using hydrogen peroxide in patients with cervical cancer.
    Mol Clin Oncol. 2021;15:142.
    PubMed         Abstract available

    Mol Med Rep

  111. ZHU L, Chen R, Jiang C, Xie Q, et al
    Mechanism underlying long noncoding RNA ILF3AS1mediated inhibition of cervical cancer cell proliferation, invasion and migration, and promotion of apoptosis.
    Mol Med Rep. 2021;24.
    PubMed         Abstract available


  112. FENG J, Mansouripour A, Xi Z, Zhang L, et al
    Nujiangexanthone A Inhibits Cervical Cancer Cell Proliferation by Promoting Mitophagy.
    Molecules. 2021;26.
    PubMed         Abstract available

  113. CHITSIKE L, Duerksen-Hughes PJ
    PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.
    Molecules. 2021;26.
    PubMed         Abstract available

    Nat Methods

    Organoid systems to recapitulate cervical cancer.
    Nat Methods. 2021;18:596.

    Oncol Lett

  115. LU X, Song X, Hao X, Liu X, et al
    MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2.
    Oncol Lett. 2021;22:539.
    PubMed         Abstract available

    Oncol Rep

  116. SONG X, Shi B, Huang K, Zhang W, et al
    [Retracted] miR133a inhibits cervical cancer growth by targeting EGFR.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

  117. CHU J, Gao J, Wang J, Li L, et al
    Mechanism of hydrogen on cervical cancer suppression revealed by highthroughput RNA sequencing.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

    PLoS One

  118. BADRE-ESFAHANI S, Petersen LK, Tatari CR, Blaakaer J, et al
    Perceptions of cervical cancer prevention among a group of ethnic minority women in Denmark-A qualitative study.
    PLoS One. 2021;16:e0250816.
    PubMed         Abstract available

    Pol J Pathol

  119. ZALEWSKA-OTWINOWSKA K, Macios A, Komerska K, Rekosz M, et al
    Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland - a pilot evaluation.
    Pol J Pathol. 2021;72:75-83.
    PubMed         Abstract available


  120. D'ALTON P, Craddock F, Bergin N, Lynch J, et al
    Exploring the lived experience of partners of women impacted by cervical cancer and the CervicalCheck screening failure in Ireland.
    Psychooncology. 2021 Jun 7. doi: 10.1002/pon.5742.
    PubMed         Abstract available

    Public Health

  121. YIMER NB, Mohammed MA, Solomon K, Tadese M, et al
    Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis.
    Public Health. 2021;195:105-111.
    PubMed         Abstract available

    Radiol Med

  122. RUSSO L, Gui B, Micco M, Panico C, et al
    The role of MRI in cervical cancer > 2 cm (FIGO stage IB2-IIA1) conservatively treated with neoadjuvant chemotherapy followed by conization: a pilot study.
    Radiol Med. 2021 May 31. pii: 10.1007/s11547-021-01377.
    PubMed         Abstract available

    Radiol Phys Technol

  123. YAEGASHI Y, Sasaki K
    High-dose-rate brachytherapy using inverse planning optimization with tandem and ovoid applicators for locally advanced cervical cancer: a simulation study.
    Radiol Phys Technol. 2021 Jun 2. pii: 10.1007/s12194-021-00624.
    PubMed         Abstract available

    Reprod Sci

  124. WU Q, Lu S, Zhang L, Zhao L, et al
    LncRNA HOXA-AS2 Activates the Notch Pathway to Promote Cervical Cancer Cell Proliferation and Migration.
    Reprod Sci. 2021 Jun 2. pii: 10.1007/s43032-021-00626.
    PubMed         Abstract available

    Rev Med Liege

  125. LAPAILLE L, De Cuypere M, Goffin F, Kakkos A, et al
    [Locally-advanced cervix cancer : multidisciplinary management].
    Rev Med Liege. 2021;76.
    PubMed         Abstract available

    Sci Rep

  126. WANG R, Zhu J, Yang S, Chen X, et al
    Therapeutic effects and prognostic factors of (125)I brachytherapy for pelvic recurrence after early cervical cancer surgery.
    Sci Rep. 2021;11:11356.
    PubMed         Abstract available

    Strahlenther Onkol

  127. SCHILLER K, Combs SE
    [Effectiveness of sequential vs concurrent chemoradiation or radiation alone in the adjuvant treatment of cervical cancer after hysterectomy].
    Strahlenther Onkol. 2021 May 30. pii: 10.1007/s00066-021-01796.

    Womens Health (Lond)

  128. EMRU K, Abebaw TA, Abera A
    Role of awareness on cervical cancer screening uptake among HIV positive women in Addis Ababa, Ethiopia: A cross-sectional study.
    Womens Health (Lond). 2021;17:17455065211017041.
    PubMed         Abstract available

  129. FOWLER JR, Maani EV, Jack BW, Miller JL, et al
    Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve.
    Womens Health (Lond). 2021;17:17455065211017070.
    PubMed         Abstract available

    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

  130. DENG C, Zhu K, Liu T, Chen L, et al
    [G6PC knockdown blocks AKT/mTOR pathway to inhibit proliferation, invasion and migration of cervical cancer HeLa cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2021;37:520-526.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.